Home Department: undeclared
Supported by: Bio-X
Mentor: Stephen Skirboll, Neurosurgery

Using a novel live cell array technology, nearly 300 cell surface markers have been screened to determine the 12 best candidate positive markers that may identify cancer stem cells in human glioblastoma (GBM). Cindy will use 2 classic in vitro validation studies to help determine which of these 12 top markers have higher propensity for forming tumors. Cindy will also use the assays to study combinations of the top 2-4 markers to determine which combination best identifies the critical cancer stem cell subpopulations in GBM.

Poster presented at the Stanford Bio-X Interdisciplinary Initiatives Symposium on August 24, 2017:

Validation Studies of Live Cell Array-Derived Markers to Identify Cancer Stem Cells in GBM

Cindy Liu¹, Hai Li¹, Stephen Skirboll¹
[Department of Neurosurgery¹, Stanford University]